Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity

References

• Abel EL, Bilitzke PJ. A possible alarm substance in the Forced Swimming Test. Physiol Behav 1990;48:233–239.
   PubMed Web of Science ®Google Scholar
• Access Economics. (2009). Keeping Dementia Front of Mind: Incidence & Prevalence 2009–2050. Alzheimer’s Australia, Canberra.
   Google Scholar
• Bastianetto S, Dumont Y, Quirion R. Catechins and resveratrol as protective polyphenols against beta-amyloid-induced toxicity: possible significance to Alzheimer’s disease. In: Ramassamy C, Bastianetto S, eds. Recent Advances on Nutrition and the Prevention of Alzheimer’s disease. Kerala, India: Transworld Research Network, Inc., 2011:145–154.
   Google Scholar
• Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882–888.
   PubMed Web of Science ®Google Scholar
• Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 2003;75:547–555.
   PubMed Web of Science ®Google Scholar
• Bloom DE, Cafiero ET, Jane-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S et al. The global economic burden of noncommunicable diseases. World Economic Forum, Geneva 2011. Available at: www.weforum.org. REF: 080911.
   Google Scholar
• Bondy B. Pathophysiology of depression and mechanisms of treatment, Dialogues. Clin Neurosci 2002;4:7–20.
   Google Scholar
• Calvo P, Gouritin B, Chacun H, Desmaële D, D’Angelo J, Noel JP et al. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm Res 2001;18:1157–1166.
   PubMed Web of Science ®Google Scholar
• Calvo PC, Remunan-Lopez J, Vila-Jato L, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carrier. J Appl Polym Sci 1997;63:125–132.
   Web of Science ®Google Scholar
• Cerutti PA. Prooxidant states and cancer. Science 1985;227:375–381.
   PubMed Web of Science ®Google Scholar
• Chhillar R, Dhingra D. Antidepressant-like activity of gallic acid in mice subjected to unpredictable chronic mild stress. Fund Clin Pharmacol 2012. DOI: 10.1111/j.1472-8206.2012.01040.x.
   PubMed Web of Science ®Google Scholar
• Claiborne A. Handbook of Methods for Oxygen Radical Research. Boca Raton: CRC, 1985.
   Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–133.
   PubMed Web of Science ®Google Scholar
• Doung H, Jiang M. Fabrication, characterization and drug loading of pH dependent multi-morphological nanoparticles based on cellulose. Polym Int 2007;56:1206–1212.
   Web of Science ®Google Scholar
• Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci 2012;47:6–15.
   PubMed Web of Science ®Google Scholar
• Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 2005;44:65–73.
   PubMed Web of Science ®Google Scholar
• Gelenberg AJ. The prevalence and impact of depression. J Clin Psychiatry 2010;71:e06.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JM. The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 1995;18:125–126.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721–724.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Antioxidants: the basics–what they are and how to evaluate them. Adv Pharmacol 1997;38:3–20.
   PubMedGoogle Scholar
• Hans ML, Lowman AM. Biodegradable NPs for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002;6:319–327.
   Web of Science ®Google Scholar
• Hansen CM, Just L. Prediction of environmental stress cracking in plastics with Hansen solubility parameters. Ind Eng Chem Res 2001;40:21–25.
   Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002;297:353–356.
   PubMed Web of Science ®Google Scholar
• Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241–251.
   PubMed Web of Science ®Google Scholar
• Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974;11:151–169.
   PubMed Web of Science ®Google Scholar
• Joshi SA, Chavhan SS, Sawant KK. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharm 2010;76:189–199.
   PubMed Web of Science ®Google Scholar
• Karnovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J Cell Biol 1965;27:137A–138A.
   Web of Science ®Google Scholar
• Klein WL. ADDLs & protofibrils–the missing links? Neurobiol Aging 2002;23:231–235.
   PubMed Web of Science ®Google Scholar
• Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001;47:65–81.
   PubMed Web of Science ®Google Scholar
• Krishnan KRR. Monoamine oxidase inhibitors. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Press Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press, Inc., 1998:239–249.
   Google Scholar
• Krogh R, Yunes RA, Andricopulo AD. Structure-activity relationships for the analgesic activity of gallic acid derivatives. Farmaco 2000;55:730–735.
   PubMedGoogle Scholar
• Kumar R, Agarwal AK, Seth PK. Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem 1995;64:1703–1707.
   PubMed Web of Science ®Google Scholar
• Levites Y, Amit T, Youdim MB, Mandel S. Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 2002;277:30574–30580.
   PubMed Web of Science ®Google Scholar
• Lu Z, Nie G, Belton PS, Tang H, Zhao B. Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. Neurochem Int 2006;48:263–274.
   PubMed Web of Science ®Google Scholar
• Millan MJ. The role of monoamines in the actions of established and “novel” antidepressant agents: a critical review. Eur J Pharmacol 2004;500:371–384.
   PubMed Web of Science ®Google Scholar
• Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci 2003;6:252–273.
   PubMed Web of Science ®Google Scholar
• Nagpal K, Singh SK, Mishra DN. Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull 2010;58:1423–1430.
   PubMed Web of Science ®Google Scholar
• Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol 2012;98:99–143.
   PubMed Web of Science ®Google Scholar
• National Institute of Health (NIH). U.S. Department of Health & Human Services. Publication No. 11–3561, Revised 2011. Available at: http://www.nimh.nih.gov.
   Google Scholar
• Nixon JR. Release characteristics of microcapsules. In: Lim F, ed. Biomedical Applications of Microcapsulation. Boca Raton, FL: CRC Press, Inc., 1983:19–52.
   Google Scholar
• Novío S, Núñez MJ, Amigo G, Freire-Garabal M. Effects of Fluoxetine on the oxidative status of peripheral blood leucocytes of restraint-stressed mice. Basic Clin Pharmacol Toxicol 2011;109:365–371.
   PubMed Web of Science ®Google Scholar
• O’Neil MJ, Smith A, Heckelman PE, Obenchain JR, Gallipeau JAR, D’Arecca MA. Gallic Acid. In: O’Neil MJ, Smith A, Heckelman PE, Obenchain JR, Gallipeau JAR, D’Arecca MA, eds. The Merck Index. New Jersey, USA: Merck Research Laboratories, Inc., 2001:261.
   Google Scholar
• Olivier JC, Huertas R, Lee HJ, Calon F, Pardridge WM. Synthesis of pegylated immunonanoparticles. Pharm Res 2002;19:1137–1143.
   PubMed Web of Science ®Google Scholar
• Pae CU, Marks DM, Han C, Patkar AA. Does minocycline have antidepressant effect? Biomed Pharmacother 2008;62:308–311.
   PubMed Web of Science ®Google Scholar
• Pan Y, Kong L, Xia X, Zhang W, Xia Z, Jiang F. Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacol Biochem Behav 2005;82:686–694.
   PubMed Web of Science ®Google Scholar
• Phiriyawirut M, Phaechamud T. Gallic acid-loaded cellulose acetate electrospun nanofibers: thermal properties, mechanical properties, and drug release behavior. Open J Polymer Chem 2012;2:21–29.
   Google Scholar
• Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977;229:327–336.
   PubMedGoogle Scholar
• Prabaharan M, Mano JF. Chitosan-based particles as controlled drug delivery systems. Drug Deliv 2005;12:41–57.
   PubMed Web of Science ®Google Scholar
• Rasool MK, Sabina EP, Ramya SR, Preety P, Patel S, Mandal N et al. Hepatoprotective and antioxidant effects of gallic acid in paracetamol-induced liver damage in mice. J Pharm Pharmacol 2010;62:638–643.
   PubMed Web of Science ®Google Scholar
• Rodrguez VMJ, Alberto MR, de Nadra MMC. Antibacterial effect of phenolic compounds from Dif-ferent Wines. Food Control 2007;18:93–101.
   Web of Science ®Google Scholar
• Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C. Neurotherapeutic applications of nanoparticles in Alzheimer’s disease. J Control Release 2011;152:208–231.
   PubMed Web of Science ®Google Scholar
• Sawa T, Nakao M, Akaike T, Ono K, Maeda H. Alkylperoxyl radical-scavenging activity of various flavonoids and other phenolic compounds: implications for the anti-tumor-promoter effect of vegetables. J Agric Food Chem 1999;47:397–402.
   PubMed Web of Science ®Google Scholar
• Shahrzad S, Aoyagi K, Winter A, Koyama A, Bitsch I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr 2001;131:1207–1210.
   PubMed Web of Science ®Google Scholar
• Sies H. Free radicals in human diseases. Am J Med 1991;91:31–38.
   PubMed Web of Science ®Google Scholar
• Sies H. Physiological role of free radicals. Exp Physiol 1997;82:291–295.
   PubMed Web of Science ®Google Scholar
• Skolnick P. Beyond monoamine-based therapies: clues to new approaches. J Clin Psychiatry 2002;63 Suppl 2:19–23.
   PubMedGoogle Scholar
• Steru L, Chermat R, Thierry B, Simon P. The Tail Suspension Test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985;85:367–370.
   PubMed Web of Science ®Google Scholar
• Sun AY, Chen YM. Oxidative stress and neurodegenerative disorders. J Biomed Sci 1998;5:401–414.
   PubMed Web of Science ®Google Scholar
• Sun W, Xie C, Wang H, Hu Y. Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. Biomaterials 2004;25:3065–3071.
   PubMed Web of Science ®Google Scholar
• Tadros TF. Applied Surfactants Principles and Applications. In: Tadros TF, ed. Weinheim: Wiley-Vch Verlag GmbH & Co. Inc. KGaA, 2005:112–115.
   Google Scholar
• Tamai I, Tsuji A. Drug delivery through the blood brain barrier. Adv Drug Deliv Rev 1996;19:401–424.
   Web of Science ®Google Scholar
• Terry RD. An honorable compromise regarding amyloid in Alzheimer disease. Ann Neurol 2001;49:684.
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai W, Limpeanchob N. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int J Pharm 2007;329:142–149.
   PubMed Web of Science ®Google Scholar
• van Rooy I, Cakir-Tascioglu S, Hennink WE, Storm G, Schiffelers RM, Mastrobattista E. In vivo methods to study uptake of nanoparticles into the brain. Pharm Res 2011;28:456–471.
   PubMed Web of Science ®Google Scholar
• Wang X, Chi N, Tang X. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm 2008;70:735–740.
   PubMed Web of Science ®Google Scholar
• Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 2010;5:51–66.
   PubMed Web of Science ®Google Scholar
• Wills ED. Mechanisms of lipid peroxide formation in tissues. role of metals and haematin proteins in the catalysis of the oxidation unsaturated fatty acids. Biochim Biophys Acta 1965;98:238–251.
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Muthu MS, Vinothapooshan G. Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of rivastigmine to treat Alzheimer’s disease. Ther Deliv 2011;2:599–609.
   PubMedGoogle Scholar
• Wilson B, Samanta MK, Santhi K, Kumar KP, Ramasamy M, Suresh B. Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomedicine 2010;6:144–152.
   PubMed Web of Science ®Google Scholar
• Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001;54:176–186.
   PubMed Web of Science ®Google Scholar
• Zafir A, Banu N. Antioxidant potential of Fluoxetine in comparison to Curcuma longa in restraint-stressed rats. Eur J Pharmacol 2007;572:23–31.
   PubMed Web of Science ®Google Scholar